Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 May;129(5):599-609.
doi: 10.1007/s00418-008-0395-x. Epub 2008 Feb 21.

Galectin-1 induced activation of the apoptotic death-receptor pathway in human Jurkat T lymphocytes

Affiliations

Galectin-1 induced activation of the apoptotic death-receptor pathway in human Jurkat T lymphocytes

Bettina Brandt et al. Histochem Cell Biol. 2008 May.

Abstract

Galectin-1 (gal-1), a member of the family of beta-galactoside binding proteins, participates in several biological processes such as immunomodulation, cell adhesion, regulation of cell growth and apoptosis. The aim of this study was to investigate whether gal-1 interferes with the Fas (Apo-1/CD95)-associated apoptosis cascade in the T-cell lines Jurkat and MOLT-4. Gal-1 and an Apo-1 monoclonal antibody (mAb) induced DNA-fragmentation in Jurkat T-cells whereas MOLT-4 cells were resistant. Gal-1 stimulated DNA-fragmentation could be efficiently inhibited by caspase-8 inhibitor II (Z-IETD-FMK) and a neutralizing Fas mAb. Fas could be identified as a target for gal-1 recognition as demonstrated by immunofluorescence staining, binding of the receptor glycoprotein to immobilized gal-1 and analyses by immunoblotting as well as by liquid chromatography-tandem mass spectrometry (LC-MS/MS). Gal-1 stimulates the activation and proteolytic processing of procaspase-8 and downstream procaspase-3 in Jurkat-T cells. Inhibition of gal-1 induced procaspase-8 activation by a neutralizing Fas mAb strongly suggests that gal-1 recognition of Fas is associated with caspase-8 activation. Our data provide the first experimental evidence for targeting of gal-1 to glycotopes on Fas and the subsequent activation of the apoptotic death-receptor pathway.

PubMed Disclaimer

References

    1. Glycobiology. 2002 Oct;12(10):127R-36R - PubMed
    1. Anal Biochem. 1976 May 7;72:248-54 - PubMed
    1. J Immunol. 2004 Sep 15;173(6):3825-37 - PubMed
    1. J Biomed Sci. 2005;12(1):13-29 - PubMed
    1. Immunol Lett. 1999 Apr 15;67(3):193-202 - PubMed

Publication types

MeSH terms

LinkOut - more resources